AI-generated summary
Helen Giza led Fresenius Medical Care as CEO for four years; before that, she was the company's CFO for three years. Shervin Korangy has been a member of the supervisory board since 2023 and was previously head of BVI Medical, a US manufacturer of surgical products.
Change at the top of the dialysis group Fresenius Medical Care (FMC) in Bad Homburg: CEO Helen Giza will soon be leaving the company and will be succeeded by Shervin Korangy on October 12th, as FMC announced. The 51-year-old was appointed unanimously by the supervisory board.
The company did not give exact reasons for the change. The 58-year-old Giza had headed FMC for four years; before that, she was said to have been chief financial officer for three years. Her successor Korangy has been on the supervisory board of Fresenius Medical Care since 2023 and has now resigned from his position. Most recently, he was head of BVI Medical, a US manufacturer of surgical products.
The FMC supervisory board chairman Michael Sen said in a statement that the transformation goals of the past few years had largely been achieved. “In the next growth phase, the company will benefit from a different leadership profile.” According to its own information, FMC has almost 110,000 employees.
AI outlook — possibilities, not facts
Shervin Korangy will continue the strategic direction of Fresenius Medical Care in the next phase of growth.
Likely · Within months

Despite the debt and budget crisis, France is spreading a better mood in the search for international capital than Germany. At the Germany summit, experts such as Philipp Freise from KKR emphasized the need to credibly implement reform promises in order to attract investors. France's 'Choose France' summit under Macron serves as a model, while Germany wants to address international financial investors with its Invest in Germany Summit on October 20th. Although foreign investment in Germany rose to 86 billion euros in 2025, it is behind France and Great Britain in the EY Attractiveness Barometer. Experts are calling for more mobility in the labor market and investable projects to stimulate growth.

Porsche CEO Michael Leiters announced at Capital Markets Day that he would make the company smaller, more exclusive and more profitable, with some models potentially costing up to 13 million euros. At the same time, Chancellor Friedrich Merz (CDU) warned at the Germany summit against giving his vote to the AfD, as this was playing the extremists' game and destroying credibility, after an AfD MP in Saxony-Anhalt was elected president of the state parliament.

The DAX lost 1.35 percent to 25,104 points, but remained above the 25,000 mark. Rising oil prices due to a tropical storm in the Gulf of Mexico and Houthi attacks, as well as troubled bond markets, particularly in France, weighed on investors. At the same time, German industrial production showed a surprise 2.0 percent increase in August, while US investors took profits and the automotive sector benefited from short-term protective measures against Chinese hybrid cars.

The Dax recorded a loss of 1.3 percent to 25,104 points on Wednesday. Stress factors include political uncertainty, the devaluation of the euro and rising oil prices as a result of new tensions in the Iran conflict.

Fresenius Medical Care is separating from CEO Helen Giza early. The supervisory board justifies the step with a lack of a growth strategy. Supervisor Shervin J. Korangy will be his successor as of October 12th.

Helen Giza is leaving the dialysis group Fresenius Medical Care early after four years. The supervisory board separated from the CEO due to a lack of growth strategies. Shervin J. Korangy will be his successor.